comparemela.com

Latest Breaking News On - Arcus south east asia - Page 1 : comparemela.com

Japan s biotech firm Heartseed raises $14 3m in Series D round

The total corpus raised by Heartseed currently stands at about $74 million.

United statesKeiichi fukudaIi limited partnershipJapan coInnovation fundPequity coIv limited partnershipKeio innovation initiativeJapan co investArcus south east asiaAtsushi sakanoAspex managementKoei tecmo capitalPrivate equity co investInnovation platformMedical incubator japan

Heartseed Inc : Heartseed raises 2 billion JPY in series D funding to accelerate development of iPSC-derived stem cell therapy for heart failure

Heartseed (Heartseed Inc.), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure (HF), today announced it has raised 2 billion JPY at Series D round, bringing

Kikuo yasuiKeiichi fukudaGewinn nurIi limited partnershipHeartseed incPequity coNovo nordiskJapan coIv limited partnershipSumitomo mitsui trust investmentKeio innovation initiativeInnovation fundJapan co investArcus south east asiaAtsushi sakanoAspex management

Heartseed Raises 2 Billion JPY in Series D Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Keiichi fukudaAtsushi sakanoIi limited partnershipPequity coJapan coKeio innovation initiativeNovo nordiskIv limited partnershipInnovation fundJapan co investArcus south east asiaKoei tecmo capitalPrivate equity co investInnovation platformMedical incubator japanKeio innovation

vimarsana © 2020. All Rights Reserved.